13F Data
13F filer · CIK 1479355

VHCP Management, LLC

NEW YORK, NY · filing since Q2 2013 · last filing Feb 13, 2017
Reported value
$101.7M
+$5.2M vs prior
Positions
24
New / sold out
3 / 2
Added / reduced
2 / 2
Turnover
4.6%
buys $4.6M · sells $11.6M
Top-10 weight
84.5%

Biggest buys vs Q2 2016

ChangeSecurityShares changeChange %Est. trade value
NewCoLucid Pharmaceuticals+68,190–+$2.6M
NewAchillion Pharmaceuticals Inc+180,000–+$1.5M
NewAudentes Therapeutics+15,000–+$267.0K
AddedOcera Therapeutics+60,000+7.5%+$158.4K
AddedAlcobra Ltd+35,597+5.7%+$88.0K

Biggest sells vs Q2 2016

ChangeSecurityShares changeChange %Est. trade value
ReducedCoherus Biosciences Inc-305,505-50.0%$-8.2M
Sold outCynapsus Therapeutics Inc-108,575-100.0%$-1.8M
Sold outGlobal Blood Therapeutics-72,990-100.0%$-1.2M
ReducedREGENXBIO Inc-28,411-54.1%$-397.5K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $134.7MQ3 2013: $181.1MQ4 2013: $185.8MQ1 2014: $192.4MQ2 2014: $187.1MQ3 2014: $222.5MQ4 2014: $363.5MQ1 2015: $434.3MQ2 2015: $354.5MQ3 2015: $390.1MQ4 2015: $165.5MQ1 2016: $115.2MQ2 2016: $96.5MQ3 2016: $101.7MQ4 2016: $93.0M
Q2 2013Q4 2016

Holdings · Q3 2016

#SecuritySharesValueWeight
1DBV TechnologiesCOM456,893$32.5M31.95%
2Heron Therapeutics IncCOM1,095,734$18.9M18.57%
3Coherus Biosciences IncCOM305,505$8.2M8.05%
4Flamel Technologies S.A.COM500,000$6.2M6.10%
5Adverum BiotechnologiesCOM1,102,735$4.5M4.46%
6BioCryst Pharmaceuticals IncCOM1,005,104$4.4M4.36%
7Lipocine IncCOM849,921$3.8M3.73%
8CoLucid PharmaceuticalsCOM68,190$2.6M2.56%
9Axovant Sciences LtdCOM184,110$2.6M2.54%
10Ocera TherapeuticsCOM856,550$2.3M2.22%
14 more rows. Subscribe for $29/month to see every row, download the data and use the API.